Amplatzer™ Amulet™ Left Atrial Appendage Occluder

FDA Premarket Approval P200049

Pre-market Approval Supplement Details

The amplatzer™ amulet™ left atrial appendage occluder is a percutaneous transcatheter device intended to prevent thrombus embolization from the left atrial appendage (laa) in patients who have nonvalvular atrial fibrillation. The amplatzer™ amulet™ left atrial appendage occluder may be considered for use in patients who are at increased risk for stroke and systemic embolism based on chads2 or cha2ds2-vasc scores, suitable for short term anticoagulation therapy, and have appropriate rationale to seek a non-pharmacologic alternative to oral anticoagulation, taking into consideration the safety and effectiveness of the device.

DeviceAmplatzer™ Amulet™ Left Atrial Appendage Occluder
Generic NameSystem, Appendage Closure, Left Atrial
ApplicantAbbott Medical
Date Received2020-12-31
Decision Date2021-08-14
PMAP200049
SupplementS
Product CodeNGV 
Advisory CommitteeCardiovascular
Expedited ReviewNo
Combination Product No
Applicant Address Abbott Medical 5050 Nathan Lane North plymouth, MN 55442

Supplemental Filings

Supplement NumberDateSupplement Type
P200049Original Filing
S004 2022-06-16 30-day Notice
S003 2021-11-05 30-day Notice
S002
S001 2021-08-24 30-day Notice

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.